The search for improved systemic therapy of non-small cell lung cancer--what are today's options?

Früh, M

The search for improved systemic therapy of non-small cell lung cancer--what are today's options? [electronic resource] - Lung cancer (Amsterdam, Netherlands) Jun 2011 - 265-70 p. digital

Publication Type: Journal Article; Review

1872-8332

10.1016/j.lungcan.2011.02.020 doi


Afatinib
Angiogenesis Inhibitors--therapeutic use
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Bevacizumab
Biomarkers, Pharmacological--metabolism
Carcinoma, Non-Small-Cell Lung--drug therapy
Cetuximab
Clinical Trials as Topic
Glutamates--therapeutic use
Guanine--analogs & derivatives
Humans
Lung Neoplasms--drug therapy
Pemetrexed
Precision Medicine
Protein-Tyrosine Kinases--antagonists & inhibitors
Quinazolines--pharmacology
Quinolines--pharmacology